Novocure to Report First Quarter 2025 Financial Results
NovoCure Limited (NASDAQ: NVCR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
NovoCure Limited (NASDAQ: NVCR) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Novocure to Participate in Leerink Partners 2025 Global Healthcare Conference
NovoCure Limited (NASDAQ: NVCR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.